BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 22934709)

  • 1. FAK and HAS inhibition synergistically decrease colon cancer cell viability and affect expression of critical genes.
    Heffler M; Golubovskaya VM; Conroy J; Liu S; Wang D; Cance WG; Dunn KB
    Anticancer Agents Med Chem; 2013 May; 13(4):584-94. PubMed ID: 22934709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Focal adhesion kinase autophosphorylation inhibition decreases colon cancer cell growth and enhances the efficacy of chemotherapy.
    Heffler M; Golubovskaya VM; Dunn KM; Cance W
    Cancer Biol Ther; 2013 Aug; 14(8):761-72. PubMed ID: 23792569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A small-molecule inhibitor, 5'-O-tritylthymidine, targets FAK and Mdm-2 interaction, and blocks breast and colon tumorigenesis in vivo.
    Golubovskaya VM; Palma NL; Zheng M; Ho B; Magis A; Ostrov D; Cance WG
    Anticancer Agents Med Chem; 2013 May; 13(4):532-45. PubMed ID: 22292771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FAK inhibition with small molecule inhibitor Y15 decreases viability, clonogenicity, and cell attachment in thyroid cancer cell lines and synergizes with targeted therapeutics.
    O'Brien S; Golubovskaya VM; Conroy J; Liu S; Wang D; Liu B; Cance WG
    Oncotarget; 2014 Sep; 5(17):7945-59. PubMed ID: 25277206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of hyaluronan synthase-3 decreases subcutaneous colon cancer growth by increasing apoptosis.
    Teng BP; Heffler MD; Lai EC; Zhao YL; LeVea CM; Golubovskaya VM; Bullarddunn KM
    Anticancer Agents Med Chem; 2011 Sep; 11(7):620-8. PubMed ID: 21453239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulation of ALDH1A3, CD44 or MDR1 sensitizes resistant cancer cells to FAK autophosphorylation inhibitor Y15.
    Golubovskaya V; O'Brien S; Ho B; Heffler M; Conroy J; Hu Q; Wang D; Liu S; Cance WG
    J Cancer Res Clin Oncol; 2015 Sep; 141(9):1613-31. PubMed ID: 25656374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel small molecule inhibitor of FAK decreases growth of human pancreatic cancer.
    Hochwald SN; Nyberg C; Zheng M; Zheng D; Wood C; Massoll NA; Magis A; Ostrov D; Cance WG; Golubovskaya VM
    Cell Cycle; 2009 Aug; 8(15):2435-43. PubMed ID: 19571674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacologic blockade of FAK autophosphorylation decreases human glioblastoma tumor growth and synergizes with temozolomide.
    Golubovskaya VM; Huang G; Ho B; Yemma M; Morrison CD; Lee J; Eliceiri BP; Cance WG
    Mol Cancer Ther; 2013 Feb; 12(2):162-72. PubMed ID: 23243059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyaluronan stabilizes focal adhesions, filopodia, and the proliferative phenotype in esophageal squamous carcinoma cells.
    Twarock S; Tammi MI; Savani RC; Fischer JW
    J Biol Chem; 2010 Jul; 285(30):23276-84. PubMed ID: 20463012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of focal adhesion kinase inhibition in non-small cell lung cancer with oncogenically activated MAPK pathways.
    Zhang H; Shao H; Golubovskaya VM; Chen H; Cance W; Adjei AA; Dy GK
    Br J Cancer; 2016 Jul; 115(2):203-11. PubMed ID: 27336608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of oesophageal squamous cell carcinoma progression by in vivo targeting of hyaluronan synthesis.
    Twarock S; Freudenberger T; Poscher E; Dai G; Jannasch K; Dullin C; Alves F; Prenzel K; Knoefel WT; Stoecklein NH; Savani RC; Homey B; Fischer JW
    Mol Cancer; 2011 Mar; 10():30. PubMed ID: 21429221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The microarray gene profiling analysis of glioblastoma cancer cells reveals genes affected by FAK inhibitor Y15 and combination of Y15 and temozolomide.
    Huang G; Ho B; Conroy J; Liu S; Qiang H; Golubovskaya V
    Anticancer Agents Med Chem; 2014 Jan; 14(1):9-17. PubMed ID: 23387973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A small molecule inhibitor, 1,2,4,5-benzenetetraamine tetrahydrochloride, targeting the y397 site of focal adhesion kinase decreases tumor growth.
    Golubovskaya VM; Nyberg C; Zheng M; Kweh F; Magis A; Ostrov D; Cance WG
    J Med Chem; 2008 Dec; 51(23):7405-16. PubMed ID: 18989950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-138 and MiR-135 directly target focal adhesion kinase, inhibit cell invasion, and increase sensitivity to chemotherapy in cancer cells.
    Golubovskaya VM; Sumbler B; Ho B; Yemma M; Cance WG
    Anticancer Agents Med Chem; 2014 Jan; 14(1):18-28. PubMed ID: 23438844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of focal adhesion kinase decreases tumor growth in human neuroblastoma.
    Beierle EA; Ma X; Stewart J; Nyberg C; Trujillo A; Cance WG; Golubovskaya VM
    Cell Cycle; 2010 Mar; 9(5):1005-15. PubMed ID: 20160475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study of hyaluronan synthase inhibitor, 4-methylumbelliferone derivatives on human pancreatic cancer cell (KP1-NL).
    Morohashi H; Kon A; Nakai M; Yamaguchi M; Kakizaki I; Yoshihara S; Sasaki M; Takagaki K
    Biochem Biophys Res Commun; 2006 Jul; 345(4):1454-9. PubMed ID: 16730656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Focal adhesion kinase regulates expression of thioredoxin-interacting protein (TXNIP) in cancer cells.
    Ho B; Huang G; Golubovskaya VM
    Anticancer Agents Med Chem; 2014 Jan; 14(1):3-8. PubMed ID: 23387972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibiting the interaction of cMET and IGF-1R with FAK effectively reduces growth of pancreatic cancer cells in vitro and in vivo.
    Ucar DA; Magis AT; He DH; Lawrence NJ; Sebti SM; Kurenova E; Zajac-Kaye M; Zhang J; Hochwald SN
    Anticancer Agents Med Chem; 2013 May; 13(4):595-602. PubMed ID: 23272972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sphingosine kinase 1 promotes tumor progression and confers malignancy phenotypes of colon cancer by regulating the focal adhesion kinase pathway and adhesion molecules.
    Liu SQ; Su YJ; Qin MB; Mao YB; Huang JA; Tang GD
    Int J Oncol; 2013 Feb; 42(2):617-26. PubMed ID: 23232649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrin alpha2-mediated ERK and calpain activation play a critical role in cell adhesion and motility via focal adhesion kinase signaling: identification of a novel signaling pathway.
    Sawhney RS; Cookson MM; Omar Y; Hauser J; Brattain MG
    J Biol Chem; 2006 Mar; 281(13):8497-510. PubMed ID: 16461767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.